Cargando…

Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav–Related Liver Injury

Background: Idiosyncratic drug-induced liver injury (DILI) is a serious uncommon disease that may develop as a result of the intake of certain drugs such as the antimicrobials flucloxacillin and co-amoxiclav. The reported cases showed significant associations between DILI and various human leukocyte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshabeeb, Mohammad, Alomar, Fadhel A., Khan, Amjad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214039/ https://www.ncbi.nlm.nih.gov/pubmed/35754504 http://dx.doi.org/10.3389/fphar.2022.882962

Ejemplares similares

Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury
por: Ali, Serat-E, et al.
Publicado: (2023)

Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis
por: Ninomiya, Kohei, et al.
Publicado: (2022)

Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population
por: Na nakorn, Chalitpon, et al.
Publicado: (2020)

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine
por: Calleja, Sofía, et al.
Publicado: (2023)

Co-amoxiclav Effects on the Structural and Binding Properties of Human Serum Albumin
por: Hesami Takallu, Saeed, et al.
Publicado: (2010)

Co-amoxiclav-induced Stevens Johnson Syndrome in a child
por: Fathallah, Neila, et al.
Publicado: (2013)

Patterns of Prescribing Co-Amoxiclav to Children in Ibri Polyclinic, Oman
por: Al-Yaqoubi, Weaam S., et al.
Publicado: (2021)

SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria
por: Sortica, Vinicius A, et al.
Publicado: (2017)

Clinical factors predicting drug-induced liver injury due to flucloxacillin
por: Lindh, Mikaela, et al.
Publicado: (2018)

Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report
por: Karunathilaka, H. G. C. S., et al.
Publicado: (2020)

Characterization of amoxicillin and clavulanic-acid-responsive CD4+ And CD8+ T-cells in patients with co-amoxiclav-induced liver injury
por: Kim, Seung-Hyun, et al.
Publicado: (2014)

Identification of susceptible HLA class II co-amoxiclav genotypes based on the analysis of drug-specific T-cells from patients with liver injury
por: Saide, Katy, et al.
Publicado: (2014)

SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer
por: Koller, Stephanie, et al.
Publicado: (2022)

Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction
por: Alnasrallah, Basil, et al.
Publicado: (2016)

Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers
por: Song, Gonjin, et al.
Publicado: (2021)

Role of Kupffer cells in liver injury induced by CpG oligodeoxynucleotide and flucloxacillin in mice
por: Gao, Yuying, et al.
Publicado: (2020)

Oxidative Stress Alleviation by Sage Essential Oil in Co-amoxiclav induced Hepatotoxicity in Rats
por: El-Hosseiny, L. S., et al.
Publicado: (2016)

A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics
por: Lehtisalo, Minna, et al.
Publicado: (2022)

Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study
por: Wing, Kevin, et al.
Publicado: (2017)

SLCO1B1 Polymorphisms and Statin-Induced Myopathy
por: Stewart, Alison
Publicado: (2013)

Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
por: Taylor, Zachary L., et al.
Publicado: (2021)

Flucloxacillin and paracetamol induced pyroglutamic acidosis
por: Zand Irani, Anis, et al.
Publicado: (2021)

Alternative Splicing of the SLCO1B1 Gene: An Exploratory Analysis of Isoform Diversity in Pediatric Liver
por: van Groen, Bianca D., et al.
Publicado: (2020)

Co-Amoxiclav as empiric treatment of UTI in children: importance of surveillance in ensuring optimal empiric treatment choice
por: Trayer, James, et al.
Publicado: (2021)

Polymorphic variants of SLCO1B1 in neonatal hyperbilirubinemia in China
por: Liu, Jiebo, et al.
Publicado: (2013)

Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period
por: Al-Mutairi, Abrar M., et al.
Publicado: (2023)

Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro
por: Stolte, Maximilian, et al.
Publicado: (2020)

Development of mouse models with restricted HLA-B*57:01 presentation for the study of flucloxacillin-driven T-cell activation and tolerance in liver injury
por: Ananthula, Suryatheja, et al.
Publicado: (2023)

Oral Flucloxacillin for Staphylococcal Osteomyelitis: Obsolete or Underused?
por: Tevell, Staffan, et al.
Publicado: (2020)

The ORACLE Children Study: educational outcomes at 11 years of age following antenatal prescription of erythromycin or co-amoxiclav
por: Marlow, Neil, et al.
Publicado: (2017)

Modified Antibiotic Adjuvant Ratios Can Slow and Steer the Evolution of Resistance: Co-amoxiclav as a Case Study
por: Allen, Richard C., et al.
Publicado: (2019)

SLCO1B1 genetic variation and hormone therapy in menopausal women
por: Moyer, Ann M., et al.
Publicado: (2018)

Interaction Effects of AFB1 and MC-LR Co-exposure with Polymorphism of Metabolic Genes on Liver Damage: focusing on SLCO1B1 and GSTP1
por: Yang, Xiaohong, et al.
Publicado: (2017)

Metabolic acidosis and 5-oxoprolinuria induced by flucloxacillin and acetaminophen: a case report
por: Lanoy, Charlotte, et al.
Publicado: (2016)

Ethylmethylhydroxypyridine Succinate Is an Inhibitor but Not a Substrate of ABCB1 and SLCO1B1
por: Shchulkin, Aleksey V., et al.
Publicado: (2023)

The Emerging Role of the SLCO1B3 Protein in Cancer Resistance
por: Sun, Ruipu, et al.
Publicado: (2020)

Oral flucloxacillin and phenoxymethylpenicillin versus flucloxacillin alone for the emergency department outpatient treatment of cellulitis: study protocol for a randomised controlled trial
por: Quirke, Michael, et al.
Publicado: (2013)

The frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemia
por: Sychev, Dmitrij Alekseevitch, et al.
Publicado: (2016)

SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability
por: Zubiaur, Pablo, et al.
Publicado: (2021)

Broad-spectrum azoles and flucloxacillin: a dangerous match
por: Vangheluwe, Tine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6vs48ellq9ocf7ejnv54rqrcls